Muscular contractile failure in septic patients: Role of the inducible nitric oxide synthase pathway

American Journal of Respiratory and Critical Care Medicine

Volumn 162, Issue 6, 2000, Pages 2308-2315

  Lanone, Sophie ^b   Mebazaa, Alexandre ^b   Heymes, Christophe ^b   Henin, Dominique ^b   Poderoso, Juan Jose ^b   Panis, Yves ^b   Zedda, Christine ^b   Billiar, Timothy ^b   Payen, Didier ^b   Aubier, Michel ^b   Boczkowski, Jorge ^a  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE FIBER CONTRACTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RESPIRATION DEPRESSION; SEPSIS; SKELETAL MUSCLE;

EID: 0034524327     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.162.6.2001097     Document Type: Article

References (51)

1. Treating patients with severe sepsis
2. Inhibitors of prostaglandin synthesis or cathepsin B prevent muscle wasting due to sepsis in the rat
3. Induction of diaphragmatic nitric oxide synthase after endotoxin administration in rats
4. Tracheal occlusion pressure: A simple index to monitor respiratory muscle fatigue during acute respiratory failure in patients with chronic obstructive pulmonary disease
5. Venous thromboembolism: Risk factors and prophylaxis
6. Endotoxin-induced skeletal muscle contractile dysfunction: Contribution of nitric oxide synthases
7. Inducible NO synthase II and neuronal NO synthase I are constitutively expressed in different structures of guinea pig skeletal muscle: Implications for contractile function
8. Endogenous peroxynitrite mediates mitochondrial dysfunction in rat diaphragm during endotoxemia
9. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly
10. On the expression of nitric oxide synthase by human macrophages: Why no NO?
11. Human mononuclear phagocyte inducible nitric oxide synthase (iNOS): Analysis of iNOS mRNA, iNOS protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages
12. Nitric oxide and septic shock
13. Further characterization and comparison of inducible nitric oxide synthase in mouse, rat, and human hepatocytes
14. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
15. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies
16. Increased inducible nitric oxide synthase in skeletal muscle biopsies from patients with chronic heart failure
17. Inducible nitric oxide synthase in skeletal muscle of patients with chronic heart failure
18. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants
19. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
20. Salicylate is a transcriptional inhibitor of the inducible nitric oxide synthase in cultured cardiac fibroblasts
21. A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study
22. Identification of inducible nitric oxide synthase in human macrophages surrounding loosened hip protheses
23. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
24. Molecular cloning and expression of inducible nitric oxide synthase from human hepatocytes
25. Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo
26. New insights into the regulation of inducible nitric oxide synthesis
27. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme
28. Evidence for in vivo production in human acute lung injury
29. Contraction, relaxation, and economy of force generation in isolated human diaphragm muscle
30. N-nitro-L-arginine and N-monomethyl-L-arginine exhibit a different pattern of inactivation toward the three nitricoxide synthases
31. The simultaneous generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density lipoprotein
32. Peroxynitrite-induced cardiac myocyte injury
33. Constitutive expression and structural diversity of inducible isoform of nitric oxide synthase in human tissues
34. Prediction of clinical severity and outcome of ventilator-associated pneumonia
35. Expression of inducible nitric oxide synthase in failing and non-failing human heart
36. Heterogeneous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure
37. Nitric oxide in skeletal muscle
38. Respiratory muscle dysfunction in sepsis
39. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
40. Effects of specific chemical modification of actin
41. The oxidative inactivation of sarcoplasmic reticulum Ca2+-ATPase by peroxynitrite
42. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts
43. Microtubule dysfunction by posttranslational nitrotyrosination of a-tubulin: Anitric oxide-dependent mechanism of cellular injury
44. Lipopolysaccharide-induced increase in plasma nitrotyrosine concentrations in rats
45. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite
46. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
47. The reaction of nitric oxide with ubiquinol: Kinetic properties and biological significance
48. Superoxide and peroxinitrite generation from inducible nitric oxide synthase in macrophages
49. Peroxynitrite induces contractile dysfunction and lipid peroxidation in the diaphragm
50. The comparative toxicity of nitric oxide and peroxynitrite to Escherichia coli